Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -22.71%55.82M | -19.28%192.48M | -15.80%72.22M | 8.08%238.46M | 57.34%85.78M | 6.13%220.63M | -34.01%54.52M | 16.49%207.89M | 107.43%82.62M | 6.58%178.47M |
| Operating income | -22.71%55.82M | -19.28%192.48M | -15.80%72.22M | 8.08%238.46M | 57.34%85.78M | 6.13%220.63M | -34.01%54.52M | 16.49%207.89M | 107.43%82.62M | 6.58%178.47M |
| Cost of sales | 10.26%-48.9M | 12.40%-125.5M | 20.51%-54.49M | -15.87%-143.27M | -49.48%-68.55M | -13.67%-123.64M | -2.40%-45.86M | -45.24%-108.77M | -87.51%-44.78M | 12.97%-74.89M |
| Operating expenses | 10.26%-48.9M | 12.40%-125.5M | 20.51%-54.49M | -15.87%-143.27M | -49.48%-68.55M | -13.67%-123.64M | -2.40%-45.86M | -45.24%-108.77M | -87.51%-44.78M | 12.97%-74.89M |
| Gross profit | -60.96%6.92M | -29.64%66.98M | 2.91%17.73M | -1.85%95.2M | 98.98%17.23M | -2.15%96.99M | -77.12%8.66M | -4.30%99.12M | 137.26%37.83M | 27.25%103.58M |
| Selling expenses | 20.92%-6.08M | 6.32%-16.97M | 9.52%-7.69M | -13.49%-18.12M | -20.53%-8.5M | 11.14%-15.96M | 6.50%-7.05M | -8.86%-17.97M | -34.20%-7.54M | -60.23%-16.5M |
| Administrative expenses | -3.85%-26.87M | 16.85%-44.96M | -17.65%-25.88M | -30.08%-54.07M | -11.45%-22M | 25.79%-41.57M | -52.48%-19.74M | -41.82%-56.01M | 7.14%-12.94M | -86.03%-39.49M |
| Research and development expenses | 46.93%-3.75M | 11.78%-15.66M | 13.43%-7.07M | 12.48%-17.75M | -3.68%-8.17M | -18.06%-20.28M | -9.63%-7.88M | -93.63%-17.18M | -86.19%-7.19M | -15.55%-8.87M |
| Impairment and provision | 74.23%-762K | 58.48%-2.87M | 40.33%-2.96M | 12.06%-6.91M | -20.91%-4.96M | -86.42%-7.85M | -447.26%-4.1M | -303.84%-4.21M | -85.86%-749K | -94.59%-1.04M |
| -Other impairment is provision | 74.23%-762K | 58.48%-2.87M | 40.33%-2.96M | 12.06%-6.91M | -20.91%-4.96M | -86.42%-7.85M | -447.26%-4.1M | -303.84%-4.21M | -85.86%-749K | -94.59%-1.04M |
| Special items of operating profit | 79.45%14.84M | 134.92%16.31M | 47.35%8.27M | -10.13%6.94M | 1,344.79%5.61M | -45.55%7.73M | -106.13%-451K | 335.47%14.19M | 341.25%7.36M | -16.39%3.26M |
| Operating profit | 10.74%-15.7M | -46.51%2.83M | 15.32%-17.59M | -72.20%5.3M | 32.02%-20.77M | 6.15%19.05M | -282.09%-30.55M | -56.14%17.95M | 370.50%16.78M | -10.16%40.92M |
| Financing income | -63.60%3.11M | -10.41%14.51M | 16.22%8.56M | 195.53%16.19M | 932.40%7.36M | 679.37%5.48M | 127.07%713K | 495.76%703K | 390.63%314K | 96.67%118K |
| Financing cost | -43.22%-1.12M | 19.01%-1.57M | 19.88%-782K | -92.45%-1.94M | -144.00%-976K | 7.71%-1.01M | 24.67%-400K | 20.38%-1.09M | 43.45%-531K | 43.80%-1.37M |
| Share of profits of associates | -326.96%-522K | -11.03%1.29M | -74.50%230K | 738.15%1.45M | 299.56%902K | -65.05%173K | -4.87%-452K | 190.99%495K | ---431K | ---544K |
| Earning before tax | -48.42%-14.23M | -18.76%17.06M | 28.91%-9.59M | -11.37%21M | 56.07%-13.48M | 31.25%23.7M | -290.27%-30.69M | -53.86%18.05M | 327.90%16.13M | -9.37%39.13M |
| Tax | -127.41%-537K | 4.77%-4.73M | -46.97%1.96M | -22.22%-4.97M | -41.42%3.69M | 38.30%-4.06M | 278.34%6.31M | 14.21%-6.59M | -276.27%-3.54M | 11.21%-7.68M |
| After-tax profit from continuing operations | -93.59%-14.77M | -23.10%12.33M | 22.09%-7.63M | -18.32%16.04M | 59.85%-9.79M | 71.20%19.63M | -293.62%-24.39M | -63.54%11.47M | 348.32%12.6M | -8.91%31.45M |
| Earning after tax | -93.59%-14.77M | -23.10%12.33M | 22.09%-7.63M | -18.32%16.04M | 59.85%-9.79M | 71.20%19.63M | -293.62%-24.39M | -63.54%11.47M | 348.32%12.6M | -8.91%31.45M |
| Minority profit | 337.83%547K | 313.33%192K | 31.14%-230K | 87.52%-90K | ---334K | ---721K | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -107.00%-15.31M | -24.72%12.14M | 21.77%-7.4M | -20.77%16.13M | 61.22%-9.46M | 77.49%20.35M | -293.62%-24.39M | -63.54%11.47M | 348.32%12.6M | -8.91%31.45M |
| Basic earnings per share | -150.00%-0.05 | -20.00%0.04 | 33.33%-0.02 | -28.57%0.05 | 62.50%-0.03 | 75.00%0.07 | -300.00%-0.08 | -66.67%0.04 | 300.00%0.04 | -7.69%0.12 |
| Diluted earnings per share | -150.00%-0.05 | -20.00%0.04 | 33.33%-0.02 | -28.57%0.05 | 62.50%-0.03 | 75.00%0.07 | -300.00%-0.08 | -66.67%0.04 | 300.00%0.04 | -7.69%0.12 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.